Evidence map›Paper›PMID 17047321›Full record

ArticleDevelopmental neuroscience2007

Nifedipine suppresses self-injurious behaviors in animals.

Bonita L Blake, Amber M Muehlmann, Kiyoshi Egami, George R Breese, Darragh P Devine, H A Jinnah

Open access · bronzeAbstract read
In one paragraph

Article in Developmental neuroscience, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Experimental therapeutics for dystonia.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2008
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Bonita L BlakeDepartment of Psychiatry, University of North Carolina, Chapel Hill, USA.
Amber M Muehlmann
Kiyoshi Egami
George R Breese
Darragh P Devine
H A Jinnah
Johns Hopkins University · USUniversity of Florida · USUniversity of North Carolina at Chapel Hill · US

Funding

Neurobiology of Self-Injurious BehaviorR01HD039795 · NICHD · JOHNS HOPKINS UNIVERSITY · PI JINNAH, HYDER A · 2002 to 2005
$1.2M
NICHD NIH HHS HD39795NICHD NIH HHS R01 HD039795
6 · The paper itself

Abstract

Self-injurious behavior is a common problem in many developmental disorders. The neurobiology of this behavior is not well understood, but the differing behavioral manifestations and associations with different disorders suggest that the underlying biological mechanisms are heterogeneous. The behavioral and biological heterogeneity is also evident in several animal models, where different manifestations can be provoked under different experimental conditions. Identifying commonalities among the different mechanisms is likely to be helpful in the design of treatments useful for the broadest populations of patients. The current studies reveal that nifedipine suppresses self-injurious behavior in 4 unrelated animal models: acute administration of high doses of +/-BayK 8644 or methamphetamine in mice, dopamine agonist treatment in rats with lesions of dopamine pathways during early development and repeated administration of pemoline in rats. The effect of nifedipine does not appear to be due to nonspecific mechanisms, such as sedation, since other classes of behaviors are unaffected or exaggerated. These results suggest that nifedipine may target a common biological mechanism in the expression of self-injurious behavior, and they suggest it should be considered in the treatment of self-injury in humans.

Indexed as

3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl esterAnimalsBehavior, AnimalCalcium Channel AgonistsCalcium Channel BlockersCentral Nervous System StimulantsDisease Models, AnimalFemaleMaleMethamphetamineMiceMice, Inbred BALB CMice, Inbred C57BLNifedipineOxidopaminePemoline3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl esterCalcium Channel AgonistsCalcium Channel BlockersCentral Nervous System StimulantsMethamphetamineNifedipineOxidopaminePemolineSympatholytics

Identifiers

PMID17047321
PMCPMC2951318
OpenAlexW2053057585

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.